3 completed, 1 terminated, 1 withdrawn. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow amdoxovir: new trials by email Literature Review of amdoxovir trials Research Report on amdoxovir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects amdoxovir 300 mg bid, amdoxovir 500 mg bid - Human Immunodeficiency Virus Infection | Phase 2 | Withdrawn | RFS Pharma, LLC | 2013-04-01 | 2013-03-29 | |
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. amdoxovir 300 mg bid, amdoxovir 500 mg bid, tenofovir DF 300 mg qd - Human Immunodeficiency Virus Infection | Phase 2 | Terminated | RFS Pharma, LLC | 2 | 2012-12-01 | 2014-11-05 |
| Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV zidovudine, amdoxovir, pharmacokinetic sampling - HIV Infections | Phase 1 / Phase 2 | Completed | RFS Pharma, LLC | 24 | 2007-02-01 | 2007-05-11 |
| Adding New Drugs for HIV Infected Patients Failing Current Therapy Enfuvirtide, Amdoxovir - HIV Infections | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2021-11-01 | |
| A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection Mycophenolate mofetil, Amdoxovir - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 56 | 2021-11-01 |
HIV Infections (3) · Acquired Immunodeficiency Syndrome (2)
RFS Pharma, LLC (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2)
Argentina (2) · United States (2) · Puerto Rico (1)
Luz Pascual, MD MPH (2) · Carlos Zala, MD (1) · Daniel R. Kuritzkes, MD (1) · David Margolis, MD (1) · Scott M. Hammer, MD (1)